Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Pancreatic Fistula 1Gastroparesis 1Anastomotic Leak 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1198Oxaliplatin 1160Capecitabine 1142Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Interventional × Serum Albumin, Human × Clear all
NCT04418739 2022-06-16

Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes

Universiti Kebangsaan Malaysia Medical Centre

Phase 2 Unknown
122 enrolled
Gastrointestinal

Pancreatic Fistula, Pancreatic Neoplasms, Gastroparesis, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon âš¡